These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16075456)

  • 21. STAT signaling in head and neck cancer.
    Song JI; Grandis JR
    Oncogene; 2000 May; 19(21):2489-95. PubMed ID: 10851047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational bases for the development of EGFR inhibitors for cancer treatment.
    Bianco R; Gelardi T; Damiano V; Ciardiello F; Tortora G
    Int J Biochem Cell Biol; 2007; 39(7-8):1416-31. PubMed ID: 17596994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in the expression of androgen receptor, wild type-epidermal growth factor receptor and a mutant epidermal growth factor receptor in human prostate cancer.
    Olapade-Olaopa EO; Moscatello DK; MacKay EH; Sandhu DP; Terry TR; Wong AJ; Habib FK
    Afr J Med Med Sci; 2004 Sep; 33(3):245-53. PubMed ID: 15819472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer.
    Volante M; Saviozzi S; Rapa I; Ceppi P; Cappia S; Calogero R; Novello S; Borasio P; Papotti M; Scagliotti GV
    Cancer; 2007 Sep; 110(6):1321-8. PubMed ID: 17647268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
    Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
    J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-Myc is required for transformation of FDC-P1 cells by EGFRvIII.
    Rath O; Himmler A; Baum A; Sommergruber W; Beug H; Metz T
    FEBS Lett; 2007 May; 581(13):2549-56. PubMed ID: 17499721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells.
    Akca H; Tani M; Hishida T; Matsumoto S; Yokota J
    Lung Cancer; 2006 Oct; 54(1):25-33. PubMed ID: 16872715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of collapsin response mediator Protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII.
    Mukherjee J; DeSouza LV; Micallef J; Karim Z; Croul S; Siu KW; Guha A
    Cancer Res; 2009 Nov; 69(22):8545-54. PubMed ID: 19903856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1.
    Chen A; Xu J; Johnson AC
    Oncogene; 2006 Jan; 25(2):278-87. PubMed ID: 16170359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas.
    Xu K; Shu HK
    Cancer Res; 2007 Jul; 67(13):6121-9. PubMed ID: 17616668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor.
    Alvarez JV; Greulich H; Sellers WR; Meyerson M; Frank DA
    Cancer Res; 2006 Mar; 66(6):3162-8. PubMed ID: 16540667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.
    Perera RM; Narita Y; Furnari FB; Gan HK; Murone C; Ahlkvist M; Luwor RB; Burgess AW; Stockert E; Jungbluth AA; Old LJ; Cavenee WK; Scott AM; Johns TG
    Clin Cancer Res; 2005 Sep; 11(17):6390-9. PubMed ID: 16144944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors.
    Dobashi Y; Suzuki S; Sugawara H; Ooi A
    Hum Pathol; 2007 Jun; 38(6):914-25. PubMed ID: 17376509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermal growth factor receptor stimulation of diacylglycerol kinase.
    Montgomery RB; Moscatello DK; Wong AJ; Stahl WL
    Biochem Biophys Res Commun; 1997 Mar; 232(1):111-6. PubMed ID: 9125112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profile of differentially expressed genes mediated by the type III epidermal growth factor receptor mutation expressed in a small-cell lung cancer cell line.
    Pedersen MW; Thykjaer T; Ørntoft TF; Damstrup L; Poulsen HS
    Br J Cancer; 2001 Oct; 85(8):1211-8. PubMed ID: 11710837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of the EGFR/FKBP12/HIF-2alpha pathway identified in childhood astrocytomas by angiogenesis gene profiling.
    Khatua S; Peterson KM; Brown KM; Lawlor C; Santi MR; LaFleur B; Dressman D; Stephan DA; MacDonald TJ
    Cancer Res; 2003 Apr; 63(8):1865-70. PubMed ID: 12702575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
    Ding H; Shannon P; Lau N; Wu X; Roncari L; Baldwin RL; Takebayashi H; Nagy A; Gutmann DH; Guha A
    Cancer Res; 2003 Mar; 63(5):1106-13. PubMed ID: 12615729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on epidermal growth factor receptor signaling in vertebrate limb patterning.
    Omi M; Fisher M; Maihle NJ; Dealy CN
    Dev Dyn; 2005 Jun; 233(2):288-300. PubMed ID: 15778992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The deletion mutant EGFRvIII significantly contributes to stress resistance typical for the tumour microenvironment.
    Theys J; Jutten B; Dubois L; Rouschop KM; Chiu RK; Li Y; Paesmans K; Lambin P; Lammering G; Wouters BG
    Radiother Oncol; 2009 Sep; 92(3):399-404. PubMed ID: 19616331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early inhibition of EGFR signaling prevents diabetes-induced up-regulation of multiple gene pathways in the mesenteric vasculature.
    Benter IF; Benboubetra M; Hollins AJ; Yousif MH; Canatan H; Akhtar S
    Vascul Pharmacol; 2009 Oct; 51(4):236-45. PubMed ID: 19577003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.